Michael’s Mission partners with the Jack & Jill Late Stage Cancer Foundation
|Michael’s Mission is proud to announce our partnership with The Jack & Jill Late Stage Cancer Foundation (JAJF). JAJF is a national 501(c) (3) that treats families facing the loss of their young Mom or Dad to WOW! Experiences®…..a timeout together as a family away from their late stage cancer to fabulous destinations to create cherished, lasting memories…while they can. Michael’s Mission will provide JAJF with funding to treat more young Moms and Dads facing late stage colorectal cancer to their own WOW! Experience.Click here to read more.|
Research Funding- Michael’s Mission is proud to report our first research grant.
Title: Phase IIIB Study of Regorafenib in patients with metastatic colorectal cancer who have progressed after standard therapy.
Details: Study sponsored by Bayer for expanded access to regorafenib, which recently showed an improvement in survival in heavily pre-treated patients and is now up for FDA approval.
Funding: To assist with start-up costs to enable Weill Cornell Medical College- New York Presbyterian to open the study at the hospital, in advance of other NYC hospitals
Timing: Study was launched on August 1, 2012. Ten patients have enrolled and are receiving the study drug.
Update: On September 27, 2012, the FDA approved Regorafenib. The patients enrolled in our trial will continue to be supported until the drug is commercially available.
Cancer Connect- Goes Live!
Cancer Connect is a platform for patients and their families to connect with each other, share experiences, and provide needed support to one another. Please visit us under Connecting with Others.
More to come on Patient Services Programs currently underway